Evidence map›Paper›PMID 40227617›Full record

ArticleCancers2025

Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular Lymphoma.

María Poza, Alejandro Martin-Muñoz, Patricia López-Pereira, Gloria Figaredo, Irene Zamanillo, Rodrigo Íñiguez, Ana Carla Oliveira, Tycho Baumann, Antonia Rodríguez-Izquierdo, Carlos Grande and 8 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

María PozaDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.
Alejandro Martin-MuñozDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.ORCID 0000-0002-5180-5760
Patricia López-PereiraICO (Instituto Catalán de Oncología) L'Hospitalet, 08908 Bacelona, Spain.ORCID 0009-0003-8279-6259
Gloria FigaredoDepartment of Hematology, Hospital Gregorio Marañón, 28007 Madrid, Spain.
Irene ZamanilloDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.
Rodrigo ÍñiguezDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.ORCID 0000-0002-2804-5038
Ana Carla OliveiraICO (Instituto Catalán de Oncología) L'Hospitalet, 08908 Bacelona, Spain.ORCID 0000-0002-1543-7243
Tycho BaumannDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.
Antonia Rodríguez-IzquierdoDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.ORCID 0000-0001-6330-7729
Carlos GrandeDepartment of Hematology, Clínica Universitaria de Navarra, 31008 Madrid, Spain.
Pilar SarandesesNuclear Medicine Department, Hospital 12 de Octubre, 28041 Madrid, Spain.
Enrique RevillaPathology Department, Hospital 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0001-5394-5401
Montserrat CortésICO (Instituto Catalán de Oncología) L'Hospitalet, 08908 Bacelona, Spain.
Rosa AyalaDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.ORCID 0000-0002-2699-8353
María CalbachoDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.ORCID 0000-0001-8106-4863
Joaquín MartínezDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.ORCID 0000-0001-7908-0063
Santiago BarrioDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.ORCID 0000-0003-0793-3535
Ana Jiménez-UbietoDepartment of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, 28041 Madrid, Spain.

Funding

CRIS FoundationInstituto de salud Carlos III CP22/00082Instituto de salud Carlos III PI21/00314
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

follicular lymphoma 2interim evaluationPET/CT

Identifiers

PMID40227617
PMCPMC11988115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.